Table 2. Demographic and clinical characteristics of the second 50 patients whose sera were evaluated.
| TB | No TB | |||
|---|---|---|---|---|
| Culture positive | Culture negative | Total | p value | |
| N. 17 | N. 33 | N. 50 | ||
| Age median (IQR) | 35 (25.5–43.5) | 41 (33–49.5) | 38 (28.5–46.5) | 0.233 |
| Sex, MALE N (%) | 10 (59) | 14 (42) | 24 (48) | 0.189 |
| AFB smear score/total (%) | Score 0: 0 | Score 0: 32 (97) | Score 0: 32 (64) | <0.001 |
| Score 1: 3 (18), | Score 1: 1(3), | Score 1: 4 (8), | ||
| Score 2: 10 (59) | Score 2: 10 (20), | |||
| Score 3: 4 (23) | Score 3: 4 (8) | |||
| Solid and/or liquid culture positive | 17(100) | 0 | 17 (34) | NA |
| BCG vaccination recorded N (%) | 9 (53) | 18 (54.5) | 27 (54) | 0.953 |
| 2 unknown | 4 unknown | 6 unknown | ||
| Previous TB reported N (%) | 1 (6) | 8 (24) | 9 (18) | 0.171 |
| Other diseases N (%) | 5 (17.5) | 18 (54.5) | 23 (46) | |
| Site: Pulmonary | 16 (94) | 33 (100) | 49 (98) | |
| Unknown | 1 | |||
| TST Positive | 3 (17.5) | 7 (21) | 10 (20) | |
| Negative | 2 (11.8) | 7 (21) | 9 (18) | |
| Not done | 12 | 19 | ||
| Region of origin | Africa (8) | Africa (9) | Africa (17) | <0.001 |
| S. America (2) | S. America (13) | S. America (15) | ||
| Asia (6) | Asia (0) | Asia (6) | ||
| W.Europe (1) | W. Europe (6) | W. Europe (7) | ||
| N. America (5) | N. America (5) |
Footnotes: TST: tuberculin skin test